Recent Finacing
Recent Raise
Biocon Biologics, Biocon Ltd’s biosimilars subsidiary, develops and manufactures biosimilar medicines and operates R&D programs and manufacturing infrastructure under CEO Dr. Christiane Hamacher.
Focus Areas
Recent Investors
Valuation as of 01/07/2021
Total Raised
Funding rounds
Investors
See the team members at Biocon Biologics.